A phase II trial of docetaxel and samarium in patients with bone metastases from castration-refractory prostate cancer (CRPC) and a response or stabilization after induction docetaxel-estramustine.
暂无分享,去创建一个
C. Théodore | V. Haddad | B. Escudier | J. Lumbroso | A. Laplanche | K. Fizazi | P. Beuzeboc | D. Prapotnich | J. Bouzy | M. di Palma